- pause slideshow
Medical products derived from cannabis will be available on prescription from 1 November 2018, the home secretary Sajid Javid, has announced.
The SalvaDore says an overhauled national contract for community pharmacy in England could increase the profession’s influence in shaping the NHS of the future.
Lifestyle interventions reduce need for antihypertensive medication in overweight peopleSubscription
Researchers found that assigning overweight patients to the DASH diet and a behavioural weight management programme cut the number of patients eligible for antihypertensive medication
Statins do not prevent the development of atherosclerotic cardiovascular disease (CVD) in people without diabetes aged 75 years and over, according to a study published in the BMJ.
Although data showed benzodiazepine and Z drug use was linked to only a 6% increase in the odds of developing Alzheimer’s disease, researchers say their prescribing should be avoided if possible.
Vaping fluid becomes more toxic to cells after it has gone through the vaping process, study results show.
Analysis of children presenting in primary care has found that delaying or withholding antibiotics is the most appropriate way of treating suspected respiratory tract infections.
People with atrial fibrillation who have dementia are less likely to receive oral anticoagulants (OACs) than those without cognitive impairment, research has shown.
As healthcare professionals prepare for blockbuster biologic Humira to come off patent on 16 October 2018, we highlight what pharmacists need to know about switching from originator biologics to biosimilars in order to get the best value from these medicines.
Despite the success pharmacy had in 2017 with offering influenza vaccination to people across the UK, winter 2018 is shaping up to be a difficult season, with different vaccines for different groups, staggered deliveries until December and guidance that makes patient prioritisation a problem.
Follow the latest updates on the proposed 12% funding cuts to community pharmacy, which could result in the closure of a quarter of pharmacies in England.